BGPT: Author Review: Eva Slabáková

Explore by Goal

Quick Explanation Copied

Eva Slabáková — scientific profile (evidence-based, paper-grounded)

Based on the accessible, DOI-identified papers in the provided record, her work clusters around cancer-cell plasticity/EMT, programmed cell death/autophagy–apoptosis cross-talk, and methodological assays for cancer stem-like phenotypes, with at least one clearly marked correction. Key example papers include reviews of miR-34a regulation in cancer () and mechanistic cancer-biology studies such as EMT-associated Slug induction in prostate context (), plus an assay-method paper for clonogenic capacity in cancer and cancer stem-like cells ().

Long Explanation

Author Review: Eva Slabáková

Skeptical, science-focused critique grounded in the DOI-identified papers available in your provided record. Where the prompt does not supply full text / experimental details, I explicitly mark uncertainty and avoid over-claims.

1) What the provided record supports (known vs uncertain)

Supported by provided identifiers: Presence of publications spanning cancer-cell death biology, EMT/cell-state plasticity, and clonogenic/cancer stem-like phenotyping methods, plus at least one explicit correction notice (; ; ).
Not supported with enough detail in this prompt: Rigorous assessment of effect sizes, sample sizes, controls, and reproducibility practices inside each study (full text is not included in your record). Therefore, my rigor evaluation below is conservative and mostly structural/trajectory-based, not method-by-method.

2) Publication activity over time (from your provided counts_by_year)

Critical note: This figure only reflects the counts supplied in your prompt, not journal quality, sample sizes, or effect magnitudes.

3) Topic & methodological footprint inferred from the provided DOI papers

Cancer biology themes

MicroRNA regulation in cancer: A review centered on miR-34a alternative regulatory mechanisms (), and a separate correction record was listed in your provided dataset ().
EMT / cell-state plasticity: TGF-β1-induced EMT characterized by early SNAI2/Slug induction in a prostate hyperplasia setting ().
Programmed cell death cross-talk (apoptosis vs autophagy): Review-like mechanistic framing of Rottlerin pathways ().
Neuroendocrine transdifferentiation as a plasticity endpoint: High cell density promotes neuroendocrine transdifferentiation in prostate cancer cells ().

Measurement / assay innovation

Clonogenic capacity & cancer stem-like phenotypes: An automatic cell cloning assay for clonogenic capacity in cancer and cancer stem-like cells ().

4) Evidence strength check (what you can and cannot conclude from the provided record)

4.1 What is scientifically plausible

The repeated appearance of EMT/cell-state plasticity and programmed cell death themes across different cancers (prostate and breast are explicitly mentioned in the provided paper titles) supports a coherent research direction rather than isolated one-off claims (; ; ).

4.2 Major uncertainties / blind spots from this prompt

No full-text: The prompt provides titles/DOIs and short abstract snippets for some papers, but not the experimental details needed to evaluate internal validity (controls, blinding, replicates, endpoints, statistical modeling, and data availability).
Potential “topic overlap ≠ causal proof” risk: Recurrent keywords (EMT, apoptosis/autophagy, senescence, etc.) do not by themselves verify causal mechanistic depth; causal strength requires full-method scrutiny.
Correction record scope is unknown: A correction DOI is listed (). Without the correction text, I can’t assess whether it materially changes conclusions.

5) Visual map: example papers as a “mechanism graph” (title/DOI grounded only)

Critical note: This is a schematic derived only from the titles/abstract framing present in your prompt, not from mechanistic extraction from full-text.

6) Detailed critique: scientific strength (paper-grounded)

6.1 Strengths suggested by the record

Cross-cutting cancer cell-state focus: The EMT/plasticity thread appears in multiple contexts (prostate EMT program with early SNAI2/Slug induction; breast intratumoral antigen plasticity linked to EMT/chemoresistance framing) suggesting the author’s work targets cell-state transitions rather than only isolated biomarkers (; ).
Methodological contribution: Inclusion of an automation-oriented clonogenic assay indicates attention to functional measurement of survival/proliferation capacity, which is often a limiting step for “stem-like” functional claims ().
Engagement with therapy-resistance-relevant processes: The miR-34a regulation review is framed around reassessment of outcomes from replacement strategies, which indicates an iterative reasoning stance rather than one-directional claims ().

6.2 Limitations and what would be needed for a “high-confidence” verdict

Internal validity unknown: Without full methods, I cannot judge control adequacy for EMT induction (e.g., TGF-β dosing kinetics, EMT marker panel specificity) in the Slug-focused prostate paper ().
Replicability unknown: Automation assay claims need benchmark reproducibility statistics (inter-operator variability, plate-to-plate variance). The clonogenic assay paper is present, but those details are not included in your prompt ().
Correction effect unknown: A correction exists for the miR-34a review record, but the prompt does not provide the corrected content; thus I cannot evaluate whether it alters interpretation ().

7) “Raw-data” note (epistemic humility)

Important: This review is not a full BGPT “raw experimental results” audit of each paper, because your prompt only includes DOI identifiers plus brief abstract framing (not full-text experimental tables/figures/raw results). Therefore, the critique above is necessarily incomplete.

8) Recommended next steps (BGPT actions)

9) Visual appendix: key provided example papers (DOI list)

DOI	Paper (from prompt)	Type hint	Topic hint
10.1038/cddis.2017.495	Alternative mechanisms of miR-34a regulation in cancer	Review	miR-34a tumor suppression regulation
10.1038/s41419-018-0833-1	Correction: Alternative mechanisms of miR-34a regulation in cancer	Correction notice	administrative correction (content not shown)
10.1002/pros.21350	TGF-β1-induced EMT…early induction of SNAI2/Slug	Article	EMT ordering / Slug
10.1155/2012/980658	Alternative pathways of cancer cell death by Rottlerin	Article / pathway framing	apoptosis vs autophagy framing
10.1186/1476-4598-13-113	High cell density → neuroendocrine transdifferentiation of prostate cancer cells	Article	plasticity endpoint
10.1002/cyto.a.22273	Automatic cell cloning assay…clonogenic capacity of cancer stem-like cells	Article / assay	functional assay automation
10.1038/bjc.2017.497	Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer	Article	surface antigen plasticity/heterogeneity

10) Must-run deeper audit?

If you want a genuinely BGPT-style raw experimental results audit (figures/tables/controls/statistics extraction from full text), I need the full-text material for each DOI (or you can let BGPT fetch within its paper database).

Feedback:

Updated: May 02, 2026